Legal Opinion
CHAIRES v. NOVO NORDISK INC.
District Court, D. New Jersey
Decided December 17, 2021No. 2:17-cv-00699Unknown
1Opinion
NOT FOR PUBLICATION UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY IN RE INSULIN PRICING LITIGATION Case No. 2:17-cv-00699 (BRM) (ESK) OPINION MARTINOTTI, DISTRICT JUDGE Before the Court is Defendants Novo Nordisk, Inc. (“Novo Nordisk”), Sanofi-Aventis U.S. LCC (“Sanofi”), and Eli Lilly and Company’s (“Eli Lilly”) (collectively, “Defendants”) Partial Motion to Dismiss the putative Plaintiffs’ (“Plaintiffs”) Third Amended Class Action Complaint (“Third Amended Complaint”) pursuant to Federal Rule of Civil Procedure 12(b)(6). (ECF No. 422.) Plaintiffs oppose the motion (ECF No.…
2Cases cited77 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Erickson v. PardusSupreme Court of the United States · 2007
- Conley v. GibsonSupreme Court of the United States · 1957
- Papasan v. AllainSupreme Court of the United States · 1986
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
72 more not listed; retrieve them via the Exa API.